BS EN ISO 21393:2021
Genomics informatics. Omics Markup Language (OML)
Standard number: | BS EN ISO 21393:2021 |
Pages: | 56 |
Released: | 2021-08-11 |
ISBN: | 978 0 580 52447 9 |
Status: | Standard |
BS EN ISO 21393:2021 Genomics informatics. Omics Markup Language (OML)
Standard Number: BS EN ISO 21393:2021
Pages: 56
Released: 2021-08-11
ISBN: 978 0 580 52447 9
Name: Genomics informatics. Omics Markup Language (OML)
Status: Standard
Overview
Welcome to the future of genomics informatics with the BS EN ISO 21393:2021 standard. This comprehensive document, titled Genomics informatics. Omics Markup Language (OML), is your ultimate guide to understanding and implementing the Omics Markup Language (OML) in your genomics research and applications. Released on August 11, 2021, this 56-page standard is a must-have for professionals in the field of genomics, bioinformatics, and related disciplines.
What is Omics Markup Language (OML)?
Omics Markup Language (OML) is a standardized language designed to facilitate the exchange and analysis of omics data, which includes genomics, proteomics, metabolomics, and other related fields. OML provides a structured format for representing complex biological data, making it easier for researchers and scientists to share, compare, and analyze their findings. By adopting OML, you can ensure that your data is interoperable with other systems and can be easily integrated into larger datasets for comprehensive analysis.
Key Features and Benefits
- Standardized Format: OML provides a consistent and standardized format for representing omics data, ensuring compatibility and interoperability across different platforms and systems.
- Enhanced Data Sharing: With OML, you can easily share your data with other researchers and institutions, facilitating collaboration and accelerating scientific discoveries.
- Improved Data Analysis: The structured format of OML allows for more efficient data analysis, enabling you to extract meaningful insights from your data more quickly and accurately.
- Comprehensive Documentation: The BS EN ISO 21393:2021 standard includes detailed documentation and guidelines for implementing OML, making it easy for you to get started and ensure compliance with industry standards.
- Future-Proof: As a standardized language, OML is designed to evolve with the field of genomics, ensuring that your data remains relevant and usable as new technologies and methodologies emerge.
Who Should Use This Standard?
The BS EN ISO 21393:2021 standard is ideal for a wide range of professionals and organizations, including:
- Genomics researchers and scientists
- Bioinformaticians and data analysts
- Healthcare and medical professionals
- Pharmaceutical and biotechnology companies
- Academic and research institutions
- Government and regulatory agencies
Why Choose BS EN ISO 21393:2021?
Choosing the BS EN ISO 21393:2021 standard means you are investing in a reliable and widely recognized framework for managing and analyzing omics data. This standard is backed by the expertise and authority of the International Organization for Standardization (ISO) and the British Standards Institution (BSI), ensuring that you are using a trusted and credible resource.
Detailed Contents
The BS EN ISO 21393:2021 standard is divided into several sections, each providing in-depth information and guidelines on various aspects of OML. Some of the key sections include:
- Introduction: An overview of the importance of standardized omics data representation and the role of OML in genomics informatics.
- Data Structure: Detailed guidelines on the structure and format of OML, including examples and best practices for data representation.
- Implementation: Step-by-step instructions for implementing OML in your research and applications, including software tools and resources.
- Use Cases: Real-world examples of how OML is being used in various fields of genomics and bioinformatics, demonstrating its versatility and effectiveness.
- Compliance: Guidelines for ensuring compliance with the BS EN ISO 21393:2021 standard, including validation and verification procedures.
Conclusion
In the rapidly evolving field of genomics, having a standardized and reliable framework for managing and analyzing data is crucial. The BS EN ISO 21393:2021 standard provides you with the tools and guidelines you need to effectively implement Omics Markup Language (OML) in your research and applications. With its comprehensive documentation, standardized format, and wide range of applications, this standard is an invaluable resource for anyone involved in genomics informatics.
Don't miss out on the opportunity to enhance your research and stay ahead in the field of genomics. Invest in the BS EN ISO 21393:2021 standard today and take your data management and analysis to the next level.
BS EN ISO 21393:2021
This standard BS EN ISO 21393:2021 Genomics informatics. Omics Markup Language (OML) is classified in these ICS categories:
- 35.240.80 IT applications in health care technology
This document is applicable to the data exchange format that is designed to facilitate exchanging omics data around the world without forcing changes of any database schema.
This document specifies the characteristics of OML from the following perspectives.
From an informatics perspective, OML defines the data exchange format based on XML. This document gives guidelines for the specifications of the data exchange format, but this document excludes the database schema itself.
From a molecular side of view, this document is applicable to all kinds of omics data, while this document excludes the details of the molecules (e.g., details of genomic sequence variations or whole genomic sequence). This document is also applicable to the molecular annotations including clinical concerns and relations with other omics concerns.
From an application side of view, this document is applicable to the clinical field including clinical practice, preventive medicine, translational research, and clinical research including drug discovery. This document does not apply to basic research and other scientific fields.
From a biological species side of view, this document is applicable to the human health-associated species as human, preclinical animals, and cell lines. This document does not apply to the other biological species.